Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice

@article{Shen2011Antiinterleukin17AA,
  title={Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice},
  author={Ning Shen and Jing Wang and Mingwu Zhao and Fei Pei and Bei He},
  journal={Inhalation Toxicology},
  year={2011},
  volume={23},
  pages={212 - 218}
}
Context: Our previous study showed that the interleukin-17 (IL-17) concentration in lung tissue and in bronchoalveolar lavage fluid (BALF) of rats with tobacco-smoke-induced chronic obstructive pulmonary disease (COPD) was higher than that of control group. However, whether IL-17 inhibitor could decrease the effect of tobacco smoking is not known yet. Objectives: To investigate the significance of IL-17 antibodies (Ab) in tobacco-smoke-exposed (TSE) mice. Materials and methods: Male C57/BL6… 
Role of neutralizing anti-murine interleukin-17A monoclonal antibody on chronic ozone-induced airway inflammation in mice.
TLDR
IL-17mAb may be a useful therapy in ozone-related diseases, including COPD, because it mitigated the severity of airway hyperresponsiveness and reduced the phosphorylation of p38MAPK.
Dual interleukin-17A/F deficiency protects against acute and chronic response to cigarette smoke exposure in mice
TLDR
Combined Il17a and Il17f deficiency resulted in significant attenuation of neutrophilic inflammatory response and protection against structural lung changes after long term cigarette smoke exposure compared with WT mice.
Expression of Interleukin (IL)-10, IL-17A and IL-22 in Serum and Sputum of Stable Chronic Obstructive Pulmonary Disease Patients
TLDR
Data suggest that the increased level of IL-17A in serum and sputum plays important roles in the pathogenesis of COPD, while IL-10 secretion might be not only affected by COPD but also by cigarette smoke.
Bilirubin treatment suppresses pulmonary inflammation in a rat model of smoke-induced emphysema.
TLDR
Bilirubin attenuated smoking-induced pulmonary injury by suppressing inflammatory cell recruitment and pro-inflammatory cytokine secretion, increasing anti- inflammatory cytokine levels, and anti-oxidant SOD activity in a rat model of smoke-induced emphysema.
IL-17 in chronic obstructive pulmonary disease
TLDR
An increase in Th 17 cells was observed in patients with COPD compared with current smokers without COPD and healthy subjects, and inverse correlations were found between Th17 cells with forced expiratory volume predicted and with FEV 1 /forced vital capacity (FVC).
Oxidative stress-mediated iNKT-cell activation is involved in COPD pathogenesis
TLDR
Together, activation of iNKT cells by oxidative stress in DC and AECs participates in the development of experimental COPD, a finding that might be exploited at a therapeutic level.
Mycoplasma pneumoniae Extract Induces an IL-17-Associated Inflammatory Reaction in Murine Lung: Implication for Mycoplasmal Pneumonia
TLDR
Observations suggest that IL-17 is involved in the prolonged induction of neutrophils in mice treated with Mp extract, leading to lung inflammation and lung injury.
[Role of Interleukin 17 in Lung Carcinogenesis and Lung Cancer Progression].
  • J. Mei, Lunxu Liu
  • Medicine
    Zhongguo fei ai za zhi = Chinese journal of lung cancer
  • 2016
TLDR
The results of current studies on IL-17 and lung carcinogenesis, as well as lung cancer progression are summarized.
T cell depletion protects against alveolar destruction due to chronic cigarette smoke exposure in mice.
TLDR
This study provides proof-of-concept for more targeted approaches to inhibiting the role of T cells in emphysema development and demonstrates for the first time that therapeutic inhibition of T cell responses may be efficacious in the treatment of COPD.
Heme oxygenase-1 attenuates inflammation and oxidative damage in a rat model of smoke-induced emphysema.
TLDR
It is demonstrated that HO-1 exerts anti-inflammatory and antioxidant effects, thus attenuating the development of smoke-induced emphysema.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
[The changes and significance of interleukin-17 in rat models of chronic obstructive pulmonary disease and asthma].
TLDR
IL-17 probably recruits neutrophils into airways by enhancing the expression of ICAM-1 in airway epithelial cells, and it might play a role in pathological changes of small airways in COPD.
Exposure to cigarette smoke upregulates AP-1 activity and induces TNF-alpha overexpression in mouse lungs
TLDR
Subacute smoke-triggered lung inflammation was accompanied by inflammatory cell influx, AP-1 activation, and proinflammatory gene overexpression in mouse lungs, and EMSA demonstrated that smoke exposure enhanced activator protein (AP)-1 DNA binding activation, but only slightly changed NF-κB activation in mouse lung.
Endogenous IL-17 as a Mediator of Neutrophil Recruitment Caused by Endotoxin Exposure in Mouse Airways1
TLDR
It is indicated that endotoxin exposure causes the release of IL-17 from T lymphocytes and that this cytokine release requires the presence of macrophages, which constitutes potential targets for pharmacotherapy against exaggerated neutrophil recruitment in airway disease.
Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma.
TLDR
It is demonstrated that IL-17 expression in airways is upregulated upon allergen inhalation, and constitutes the link between allergenic-induced T cell activation and neutrophilic influx.
[The levels and clinical implications of induced sputum interleukin-17 in chronic obstructive pulmonary disease and asthma].
TLDR
The concentrations of IL-17 in patients with acute exacerbation of COPD and with asthma were significantly increased and may play a role in the airway inflammation in both COPd and asthma.
Peroxisome Proliferator-Activated Receptor γ Agonist Down-Regulates IL-17 Expression in a Murine Model of Allergic Airway Inflammation1
TLDR
The findings suggest that the therapeutic effect of PPARγ in asthma is partly mediated by regulation of IL-17 expression via NF-κB pathway.
Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop*
TLDR
Investigation of MUC5B expression demonstrated that IL-17's effect is at least partly mediated through IL-6 by a JAK2-dependent autocrine/paracrine loop, and evidence is presented to show that both IL-4, IL-9, and IL-13 mediate Muc5Bexpression through the ERK signaling pathway.
Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease.
TLDR
Bronchial neutrophilia is a key inflammatory pattern in chronic obstructive pulmonary disease patients and may represent an independent stimulus for additional airway inflammation.
Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice.
TLDR
It is demonstrated for the first time that chronic CS exposure leads to the generation of pathogenic T cells capable of inducing COPD-like disease in Rag2(-/-) mice, providing novel insights into COPD pathogenesis.
Observations on Lung Function and Pathological Changes of Airway Lung Tissues in Rats with Different Passive-somking Durations
TLDR
Within certain range, the longer the smoking time is, the more obvious the pathological changes of airway-pulmonary tissues are, and the higher the rate of airflow limitation is as well.
...
1
2
...